These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 11298536)
1. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536 [TBL] [Abstract][Full Text] [Related]
2. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris]. Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274 [TBL] [Abstract][Full Text] [Related]
3. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143 [TBL] [Abstract][Full Text] [Related]
4. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity. Koopai M; Mortazavi H; Khatami A; Khodashenas Z Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863 [TBL] [Abstract][Full Text] [Related]
5. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835 [TBL] [Abstract][Full Text] [Related]
6. Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus. Kumar B; Arora S; Kumaran MS; Jain R; Dogra S Indian J Dermatol Venereol Leprol; 2006; 72(3):203-6. PubMed ID: 16766834 [TBL] [Abstract][Full Text] [Related]
7. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity. Barnadas MA; Rubiales MV; Gich I; GelpĂ C Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029 [TBL] [Abstract][Full Text] [Related]
9. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]
10. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740 [TBL] [Abstract][Full Text] [Related]
11. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345 [TBL] [Abstract][Full Text] [Related]
12. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237 [TBL] [Abstract][Full Text] [Related]
14. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Hacker MK; Janson M; Fairley JA; Lin MS Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995 [TBL] [Abstract][Full Text] [Related]
15. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus. Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris. Sharma VK; Prasad HR; Khandpur S; Kumar A Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783 [TBL] [Abstract][Full Text] [Related]
17. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1. Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813 [TBL] [Abstract][Full Text] [Related]
18. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038 [TBL] [Abstract][Full Text] [Related]
19. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris. Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020 [TBL] [Abstract][Full Text] [Related]
20. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil. Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]